These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 24386459)
1. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow. Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459 [TBL] [Abstract][Full Text] [Related]
2. Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin. Barthel SR; Gavino JD; Wiese GK; Jaynes JM; Siddiqui J; Dimitroff CJ Glycobiology; 2008 Oct; 18(10):806-17. PubMed ID: 18647941 [TBL] [Abstract][Full Text] [Related]
3. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332 [TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs). Myung JH; Launiere CA; Eddington DT; Hong S Langmuir; 2010 Jun; 26(11):8589-96. PubMed ID: 20155985 [TBL] [Abstract][Full Text] [Related]
5. In vitro method to observe E-selectin-mediated interactions between prostate circulating tumor cells derived from patients and human endothelial cells. Gakhar G; Bander NH; Nanus DM J Vis Exp; 2014 May; (87):. PubMed ID: 24894373 [TBL] [Abstract][Full Text] [Related]
6. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Barthel SR; Wiese GK; Cho J; Opperman MJ; Hays DL; Siddiqui J; Pienta KJ; Furie B; Dimitroff CJ Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19491-6. PubMed ID: 19889975 [TBL] [Abstract][Full Text] [Related]
7. E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis. Yasmin-Karim S; King MR; Messing EM; Lee YF Oncotarget; 2014 Dec; 5(23):12097-110. PubMed ID: 25301730 [TBL] [Abstract][Full Text] [Related]
8. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286 [TBL] [Abstract][Full Text] [Related]
9. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3. Hsu JW; Yasmin-Karim S; King MR; Wojciechowski JC; Mickelsen D; Blair ML; Ting HJ; Ma WL; Lee YF Am J Pathol; 2011 Feb; 178(2):872-80. PubMed ID: 21281819 [TBL] [Abstract][Full Text] [Related]
10. HECA-452 is a non-function blocking antibody for isolated sialyl Lewis x adhesion to endothelial expressed E-selectin under flow conditions. Kummitha CM; Shirure VS; Delgadillo LF; Deosarkar SP; Tees DF; Burdick MM; Goetz DJ J Immunol Methods; 2012 Oct; 384(1-2):43-50. PubMed ID: 22820001 [TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer. Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810 [TBL] [Abstract][Full Text] [Related]
12. Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion. Geng Y; Chandrasekaran S; Hsu JW; Gidwani M; Hughes AD; King MR PLoS One; 2013; 8(1):e54959. PubMed ID: 23372803 [TBL] [Abstract][Full Text] [Related]
13. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study. Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125 [TBL] [Abstract][Full Text] [Related]
14. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells. Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102 [TBL] [Abstract][Full Text] [Related]
15. Gangliosides expressed on breast cancer cells are E-selectin ligands. Shirure VS; Henson KA; Schnaar RL; Nimrichter L; Burdick MM Biochem Biophys Res Commun; 2011 Mar; 406(3):423-9. PubMed ID: 21329670 [TBL] [Abstract][Full Text] [Related]
16. PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow. Zou X; Shinde Patil VR; Dagia NM; Smith LA; Wargo MJ; Interliggi KA; Lloyd CM; Tees DF; Walcheck B; Lawrence MB; Goetz DJ Am J Physiol Cell Physiol; 2005 Aug; 289(2):C415-24. PubMed ID: 15814589 [TBL] [Abstract][Full Text] [Related]
18. Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Dimitroff CJ; Descheny L; Trujillo N; Kim R; Nguyen V; Huang W; Pienta KJ; Kutok JL; Rubin MA Cancer Res; 2005 Jul; 65(13):5750-60. PubMed ID: 15994950 [TBL] [Abstract][Full Text] [Related]
19. Analysis of physiologic E-selectin-mediated leukocyte rolling on microvascular endothelium. Wiese G; Barthel SR; Dimitroff CJ J Vis Exp; 2009 Feb; (24):. PubMed ID: 19229187 [TBL] [Abstract][Full Text] [Related]
20. Ezrin expression in circulating tumor cells is a predictor of prostate cancer metastasis. Chen Z; Wang J; Lu Y; Lai C; Qu L; Zhuo Y Bioengineered; 2022 Feb; 13(2):4076-4084. PubMed ID: 35156523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]